Dutta, Tarun Kumar (2023) Long-term Outcome of Splenectomy in Immune Thrombocytopenia (ITP). Asian Hematology Research Journal, 7 (3). pp. 16-19.
Text
30224-Article Text-56649-2-10-20230415.pdf - Published Version
Download (377kB)
30224-Article Text-56649-2-10-20230415.pdf - Published Version
Download (377kB)
Abstract
ITP is a chronic illness with frequent mucosal bleeding. Though the first line treatment is corticosteroids, relapse is frequent which necessitates splenectomy. Response to splenectomy is usually good initially; however, over the years relapses are frequent. Drugs then used are azathioprine, mycophenolate mofetil, anti-D globulin, TPO-receptor agonists, rituximab, cyclosporine, etc. Ultimately there is a small subset of patients who may require a small dose of prednisolone lifelong.
Item Type: | Article |
---|---|
Subjects: | Universal Eprints > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 17 Apr 2023 05:00 |
Last Modified: | 09 Jan 2024 04:11 |
URI: | http://journal.article2publish.com/id/eprint/1707 |